Triple-negative breast cancer (TNBC) constituted 8/61 (13.1%) of PIK3CA-WT tumors and only 2/42 (4.8%) of mutated tumors; however, this difference was not statistically significant. This evidence concerns the gene PIK3CA and triple-negative breast carcinoma.